Dashboard
Manage Tickers

EWTX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-edgewise-therapeutics-lowers-price-target-to-30
JP Morgan Maintains Overweight on Edgewise...
08/19/2025 14:31:35

JP Morgan analyst Tessa Romero maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and lowers the price target f...

rbc-capital-maintains-outperform-on-edgewise-therapeutics-raises-price-target-to-49
RBC Capital Maintains Outperform on Edgewi...
08/08/2025 17:44:57

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and raises the price tar...

edgewise-therapeutics-q2-eps-034-beats-043-estimate
Edgewise Therapeutics Q2 EPS $(0.34) Beats...
08/07/2025 12:11:00

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of...

this-starbucks-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This Starbucks Analyst Begins Coverage On ...
06/30/2025 17:04:18

hc-wainwright--co-initiates-coverage-on-edgewise-therapeutics-with-buy-rating-announces-price-target-of-42
HC Wainwright & Co. Initiates Coverage On ...
06/30/2025 11:07:34

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Edgewise Therapeutics (NASDAQ:EWTX) with a Buy rating...

no-accelerated-fda-approval-for-edgewises-rare-muscular-disease-drug-shares-fall
No Accelerated FDA Approval For Edgewise's...
06/26/2025 17:29:30

Edgewise reports sustained functional stability in Becker patients and selects Phase 3 dose for Duchenne after positive Phase 2...

edgewise-therapeutics-reports-results-in-sevasemten-program-for-becker-and-duchenne-muscular-dystrophies
Edgewise Therapeutics Reports Results in S...
06/26/2025 10:04:07

Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a leading muscle disease biopharmaceutical company, today unveiled positive results...

rbc-capital-reiterates-outperform-on-edgewise-therapeutics-maintains-48-price-target
RBC Capital Reiterates Outperform on Edgew...
06/05/2025 14:05:55

RBC Capital analyst Leonid Timashev reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $48 price...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
05/12/2025 12:08:42

edgewise-therapeutics-q1-eps-043-inline
Edgewise Therapeutics Q1 EPS $(0.43), Inline
05/08/2025 12:04:28

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.43) per share which met the analyst consensus estimate. Th...

wedbush-maintains-outperform-on-edgewise-therapeutics-maintains-43-price-target
Wedbush Maintains Outperform on Edgewise T...
04/21/2025 15:13:01

Wedbush analyst Laura Chico maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $43 price target.

tesla-nvidia-apple-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Tesla, Nvidia, Apple And Other Big Stocks ...
04/21/2025 12:24:45

top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-q2
Top 3 Health Care Stocks That Could Lead T...
04/10/2025 10:56:54

rbc-capital-maintains-outperform-on-edgewise-therapeutics-lowers-price-target-to-52
RBC Capital Maintains Outperform on Edgewi...
04/03/2025 15:17:56

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and lowers the price tar...

scotiabank-downgrades-edgewise-therapeutics-to-sector-perform-lowers-price-target-to-14
Scotiabank Downgrades Edgewise Therapeutic...
04/03/2025 14:29:20

Scotiabank analyst Louise Chen downgrades Edgewise Therapeutics (NASDAQ:EWTX) from Sector Outperform to Sector Perform and l...

piper-sandler-maintains-overweight-on-edgewise-therapeutics-maintains-51-price-target
Piper Sandler Maintains Overweight on Edge...
04/02/2025 17:53:26

Piper Sandler analyst Yasmeen Rahimi maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and maintains $51 price...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
04/02/2025 17:06:16

edgewise-therapeutics-sees-meaningful-hcm-treatment-gains-with-edg-7500-in-phase-2-study
Edgewise Therapeutics Sees Meaningful HCM ...
04/02/2025 16:27:12

Edgewise's EDG-7500 lowered LVOT gradient and NT-proBNP levels in HCM patients, improving symptoms. Initial Part D data is ...

why-edgewise-therapeutics-ewtx-stock-is-falling
Why Edgewise Therapeutics (EWTX) Stock Is ...
04/02/2025 14:20:40

Edgewise Therapeutics shares are trading lower by 25.7% during Wednesday's session. The company announced an approximate $2...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/02/2025 12:05:45

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION